Explore strong dividend paying companies in the Healthcare industry. It provides services across approximately 69 homes in New South Wales, Queensland, South Australia and Victoria. EHE is forecast to become profitable over the next 3 years, which is considered above average market growth. The Financial and Risk business of Thomson Reuters is now. PEG Ratio: Insufficient data to calculate EHE's PEG Ratio to determine if it is good value. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions. Quality Earnings: EHE is currently unprofitable. Who are the major shareholders and have insiders been buying or selling? You must be a registered user to save alerts. Growing Dividend: Insufficient data to determine if EHE's dividend payments have been increasing. Read More » Growing Profit Margin: EHE is currently unprofitable. Estia Health Ltd (EHE:ASX) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Estia Health (ASX:EHE) ... EHE Share Price and Trading History. Read More » S&P/ASX 200 To Open Lower, 3 ASX Shares To Watch is forecast to be low in 3 years time (4.4%). High Growth Revenue: EHE's revenue (2.9% per year) is forecast to grow slower than 20% per year. Australia and Victoria. 0.025 (-1.39%) 52 Week Range. Collapsed. Earnings Trend: EHE is unprofitable, and losses have increased over the past 5 years at a rate of 13.5% per year. It provides services across approximately 69 homes in New South Wales, Queensland, South. Estia Health Limited operates residential aged care homes in Australia. Estia Health Ltd. Debt Coverage: EHE's debt is well covered by operating cash flow (96.9%). Accelerating Growth: Unable to compare EHE's earnings growth over the past year to its 5-year average as it is currently unprofitable. What Kind Of Shareholders Hold The Majority In Estia Health Limited's (ASX:EHE) Shares? Mr. Ian Thorley is Chief Executive Officer and Managing Director at Estia Health Limited since November 23, 2018. Return vs Market: EHE underperformed the Australian Market which returned -1.6% over the past year. ASX jumps on hope for COVID-19 drug remdesivir, ... Shares in Estia Health have dropped by 3.3 per cent to $1.45, ... driving up their share prices to record high levels. The Clinuvel (ASX:CUV) share price edges down on Q1 update. Earnings vs Savings Rate: EHE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%). How experienced are the management team and are they aligned to shareholders interests? Please sign in or register. Estia Health Ltd is an Australia-based company that is engaged in the provision of services in residential aged care homes in Australia. Its clinical care services include regular reviews and includes daily medication; pain management programs; medical services, such physiotherapy, pharmacy, podiatry, optometry and dental; specialist dementia care and personal care. More Details, Trading at 63.2% below our estimate of its fair value, Earnings are forecast to grow 75.7% per year. Return vs Industry: EHE underperformed the Australian Healthcare industry which returned -4.8% over the past year. Analysts covering Estia Health currently have a consensus Earnings Per Share (EPS) forecast of 0.058 for the next financial year. Experienced Board: EHE's board of directors are considered experienced (3.7 years average tenure). Health & Biotech. Estia Health Limited operates residential aged care homes in Australia. What is Estia Health current dividend yield, its reliability and sustainability? ASX:EHE Price Estimation Relative to Market, March 19th 2020. Estia Health's P/E tells us that market participants think it will not fare as well as its peers in the same industry. EHE's revenue (2.9% per year) is forecast to grow slower than 20% per year. It has 68 operational homes and 6,046 operational places for residents with over 7,000 employed staff. Unable to compare EHE's earnings growth over the past year to its 5-year average as it is currently unprofitable. Future Dividend Coverage: No need to calculate the sustainability of EHE's dividend in 3 years as they are not forecast to pay a notable one for the Australian market. View announcements, advanced pricing charts, trading status, fundamentals, dividend information, peer … It offers various general activities, such as gardening, reading, movies, music, parties, cultural celebrations, art sessions or daytrips, lifestyle coordinators can also cater for specialist interests. Compensation vs Earnings: Ian's compensation has been consistent with company performance over the past year. The Estia Health Ltd (ASX: EHE) share price is tumbling lower today as the aged care provider officially gets cut from the S&P/ASX 200 Index. He joined Estia Health in October 2016. Aged care operator Estia falls to loss as COVID-19 costs bite August 18, 2020 | Rachel Williamson. Share price information may be rounded up/down and therefore not entirely accurate. Find out more at Intelligent Investor How has Estia Health's share price performed over time and what events caused price changes? Mr. Ian Thorley is Chief Executive Officer and Managing Director at Estia Health Limited since November 23, 2018. Data delayed at least 20 minutes, as of Jan 15 2021 05:10 GMT. Earnings vs Market: EHE is forecast to become profitable over the next 3 years, which is considered above average market growth. News. $1.77. View the latest share news for ESTIA HEALTH and ASX:EHE RNS announcements, along with all the share chat by members of the Stockopedia community Explore growth companies in the Healthcare industry. FT is not responsible for any use of content by you outside its scope as stated in the. Notable Dividend: Unable to evaluate EHE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts. High Dividend: Unable to evaluate EHE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts. No risks detected for EHE from our risk checks. HotCopper has news, discussion, prices and market data on ESTIA HEALTH LIMITED. How is Estia Health forecast to perform in the next 1 to 3 years based on estimates from 6 analysts? Estia Health Ltd is an Australia-based company that is engaged in the provision of services in residential aged care homes in Australia. 337927). 1 Year Return. Check Estia Health Limited (ASX:EHE) Share Price, Stock News, Stock Chart, Trends, Market Data, Announcements and Unique Analysis on Kalkine Media Mon, January 11, 2021 Australia Edition The Estia Health Ltd share price is down almost 4% in response to a trading update.. Estia is one of the largest aged care providers in Australia, it has been operating for around 50 years. As of June 30, 2020, it had 69 homes, which include 6,182 resident places in New South Wales, Queensland, South Australia, and Victor... Show more. Is Estia Health (ASX:EHE) Using Too Much Debt? Find out more at Intelligent Investor Insufficient data to determine if EHE's dividends per share have been stable in the past. EHE's short term assets (A$50.6M) do not cover its. Markit Short Selling Activity © Markit. Estia Health Limited operates residential aged care homes in Australia. Estia Health Limited (EHE) Announcements. Collapsed. According to a note out of Morgan Stanley, its analysts have downgraded this aged care operator’s shares to an underweight rating with a reduced price target of $1.50. EHE's is expected to become profitable in the next 3 years. (-19.2%), as it is currently unprofitable. EHE:ASX price moved over -1.12% to 1.77 Dec 24 2020 Key statistics As of last trade Estia Health Ltd (EHE:ASX) traded at 1.83, -30.15% below its 52-week high of 2.62, set on Jan 23, 2020. Short Term Liabilities: EHE's short term assets (A$50.6M) do not cover its short term liabilities (A$960.3M). have bought more shares than they have sold in the past 3 months. Explore strong past performing companies in the Healthcare industry. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Estia Health FY21 Half Year Results. Rise and Shine: What you need to know before the ASX opens Insider Buying: EHE insiders have bought more shares than they have sold in the past 3 months. Interest Coverage: EHE is unprofitable, therefore interest payments are not well covered by earnings. Read detailed company information including current share prices, financial summary, directors, announcements, dividends & news. How volatile is Estia Health's share price compared to the market and industry in the last 5 years? EHE's debt to equity ratio has increased from 10% to 21.4% over the past 5 years. than the rest of Australian stocks over the past 3 months. Estia Health Ltd (ASX: EHE) Share Price and News. All rights reserved. EHE underperformed the Australian Market which returned -1.6% over the past year. Volatility Over Time: EHE's weekly volatility (9%) has been stable over the past year. It operates its homes across various locations, such as Albany Creek, Albury, Aldgate, Altona Meadows, Ardeer, Bendigo, Camden, Burton, Daw Park and Figtree. Estia Health trades on ASX (Australian Stock Exchange) under the ticker symbol "EHE". Insufficient data to determine if EHE's dividend payments have been increasing. EHE is unprofitable, and losses have increased over the past 5 years at a rate of 13.5% per year. Explore potentially undervalued companies in the Healthcare industry. One share of EHE stock can currently be purchased for approximately A$1.735. Reducing Debt: EHE's debt to equity ratio has increased from 10% to 21.4% over the past 5 years. Latest Share Price and Events Stable Share Price : EHE is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week. Join the HotCopper ASX share market forum today for free. The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price has edged 1.9% lower today following the release of its Q1 results. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. Revenue vs Market: EHE's revenue (2.9% per year) is forecast to grow slower than the Australian market (5% per year). Shares in Estia Health are currently priced at A$1.75. How does Estia Health settle dividends? Mr. Thorley was the Chief Operating Officer of Esti. ($USD585.53K) is about average for companies of similar size in the Australian market ($USD711.61K). He joined Estia Health in October 2016. Unable to evaluate EHE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts. PB vs Industry: EHE is good value based on its PB Ratio (0.7x) compared to the AU Healthcare industry average (1.8x). Dividend Coverage: EHE is not paying a notable dividend for the Australian market. (0.7x) compared to the AU Healthcare industry average (1.8x). This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Add this security to watchlist, portfolio, or create an alert to track market movement. Compensation vs Market: Ian's total compensation ($USD585.53K) is about average for companies of similar size in the Australian market ($USD711.61K). Stable Dividend: Insufficient data to determine if EHE's dividends per share have been stable in the past. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. PE vs Industry: EHE is unprofitable, so we can't compare its PE Ratio to the AU Healthcare industry average. Aged care provider Estia Health Ltd suffered a weak start in today’s trading on the ASX. Its clinical care services include regular reviews and includes daily medication; pain management programs; medical services, such physiotherapy, pharmacy, podiatry, optometry and dental; specialist dementia care and personal care. EHE has a dividend yield higher than 75% … Long term investing works well, but it doesn't always work for each individual stock. Debt Level: EHE's debt to equity ratio (21.4%) is considered satisfactory. EHE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-8.1%). Stable Share Price: EHE is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week. Estia Health Ltd (ASX: EHE) Price. View today’s EHE share price, options, bonds, hybrids and warrants. ASX Announcements and Latest News from ESTIA HEALTH LIMITED. All content on FT.com is for your general information and use only and is not intended to address your particular requirements. PE vs Market: EHE is unprofitable, so we can't compare its PE Ratio to the Australian market. When was Estia Health listed and what its ASX ticker? EHE is not paying a notable dividend for the Australian market. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. Join the HotCopper ASX share market forum today for free. How has Estia Health's share price performed over time and what events caused price changes? You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. 3. At that level they are trading at 2.4% premium to the analyst consensus target price of 0.00. EHE's revenue (2.9% per year) is forecast to grow slower than the Australian market (5% per year). Dilution of Shares: Shareholders have not been meaningfully diluted in the past year. Long Term Liabilities: EHE's short term assets (A$50.6M) do not cover its long term liabilities (A$301.3M). Future ROE: EHE's Return on Equity is forecast to be low in 3 years time (4.4%). Estia Health Limited (EHE.AX) pays an annual dividend of A$0.13 per share and currently has a dividend yield of 7.76%. Learn more here. It operates its homes across various locations, such as Albany Creek, Albury, Aldgate, Altona Meadows, Ardeer, Bendigo, Camden, Burton, Daw Park and Figtree. Movement. $0.905 - $2.62. EHE is forecast to become profitable over the next 3 years, which is considered faster growth than the. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. (2018). Explore more healthy companies in the Healthcare industry. Formed in October 2013, Estia Health Limited (ASX:EHE) is one of the leading providers of residential aged care in Australia operating 6,182 resident places across 69 homes in New South Wales, Queensland, South Australia and Victoria. Please read our Financial Services Guide before deciding whether to obtain financial services from us. No need to calculate the sustainability of EHE's dividend in 3 years as they are not forecast to pay a notable one for the Australian market. All markets data located on FT.com is subject to the. Estia Health Limited (EHE) Overview. What is Estia Health's stock price today? Investors saw the billion-dollar company’s shares sink by more than 8% in early trading. Estia Health Limited (EHE.AX) (ASX:EHE) Dividend Information Estia Health Limited (EHE.AX) pays an annual dividend of A$0.13 per share, with a dividend yield of ∞. Experienced Management: EHE's management team is considered experienced (2.8 years average tenure). Estia Health Limited's company bio, employee growth, exchange listings and data sources, Estia Health Limited operates residential aged care homes in Australia. Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. EHE is unprofitable, so we can't compare its, EHE is unprofitable, so we can't compare its. Ian's compensation has been consistent with company performance over the past year. Significantly Below Fair Value: EHE is trading below fair value by more than 20%. The Estia Health Ltd (ASX:EHE) share price is down close to 4% in reaction to the company’s half year result to December 2018. Estia Health (EHE) share price, charts, trades & the UK's most popular discussion forums. View Estia Health Limited ASX:EHE share price history, dividends & company information on SharePrices.com.au © 2018 SIMPLY WALL STREET PTY LTD, COMMUNITY DESIGN 2845206, US DESIGN PATENT #29/544/281, EUROPEAN DESIGN REGISTRATION #2845206, STANDARD & POOR’S FINANCIAL SERVICES LLC. Estia Health Limited () Stock Market info Recommendations: Buy or sell Estia Health stock? How is Estia Health's financial position? EHE's most recent interim dividend payment was made to shareholders of record on Friday, March 27. Learn more. ALL RIGHTS RESERVED. All else being equal, a share price drop should make a stock more attractive to potential investors. RELATED STOCKHEAD STORIES. To the annoyance of some shareholders, Estia Health shares are down a considerable 36% in the last month.That drop has capped off a tough year for shareholders, with the share price down 34% in that time. Tuesday 23 February 2021 commencing at 9.30am (AEDT) Estia Health Limited (ASX: EHE) (Estia or Company) advises that it will announce its FY21 Half Year results for the period ending 31 December 2020 on Tuesday 23 February 2021.Shareholders and guests will be able to pre-register by clicking here. In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of S&P Capital IQ. Copyright © 2018, Standard & Poor’s Financial Services LLC. High ROE: EHE has a negative Return on Equity (-19.2%), as it is currently unprofitable. As of June 30, 2020, it had 69 homes, which include 6,182 resident places in New South Wales, Queensland, South Australia, and Victor, Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Any information that you receive via FT.com is at best delayed intraday data and not "real time". Read detailed company information and latest announcements from Estia Health Limited including news headlines & gain/loss. 2. Fair value with moderate growth potential. Where can I find the current share price? EHE (A$1.71) is trading below our estimate of. Below Fair Value: EHE (A$1.71) is trading below our estimate of fair value (A$4.65). Free forex prices, toplists, indices and lots more. Earnings vs Industry: EHE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-8.1%). Mr. Thorley was the Chief Operating Officer of Esti... Show more. Is Estia Health undervalued compared to its fair value and its price relative to the market? Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. Estia Health's (ASX:EHE) Shareholders Are Down 78% On Their Shares. Have Insiders Been Buying Estia Health Limited (ASX:EHE) Shares? It offers various general activities, such as gardening, reading, movies, music, parties, cultural celebrations, art sessions or daytrips, lifestyle coordinators can also cater for specialist interests. EHE is trading below fair value by more than 20%. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.